What’s New in Diabetic Kidney Disease

The purpose of this activity is to discuss the pathophysiology and natural history of diabetic kidney disease, the novel drugs used to treat hyperkalemia and evaluate their appropriate use, and the mechanism of action of novel drugs under study for treating diabetic kidney disease.

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Describe what is currently known about the pathophysiology and natural history of diabetic kidney disease
  • Discuss the mechanism of action of novel drugs used to treat hyperkalemia and evaluate their appropriate use
  • Identify the mechanism of action of novel drugs under study for treating diabetic kidney disease

Target Audience

  • Physician
  • Pharmacist
  • Dietitian
Accreditation/Designation of Credit Statements:

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this online CME/CE for a maximum of 1.5 AMA PRA Category 1 Credit(s) TMPhysicians should claim only the credit commensurate with the extent of their participation in the activity. 

Pharmacist

This knowledge-based enduring activity has been assigned ACPE Universal Activity Number 0620-0000-17-035-H01-P, for 1.5 contact hours (0.15 CEUs). The activity is available for credit through September 20, 2019. To receive credit, learners must review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; complete the pre-test; complete the post-test (minimum score of 70% required) and electronic evaluation.  An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact cmeinfo@kidney.org if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Dietitian

The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

The activity is available for credit through September 20, 2019.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; complete the pre-test; and complete the post-test (minimum score of 70% required) and evaluation to successfully earn credit.  The estimated time for completion is 1.5 hours. 

If you participated in the live symposium What’s New in Diabetic Kidney Disease on Thursday, April 20, 2017 and claimed credit, you should not claim credit for this endured activity.

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 CDR CPEUs
Course opens: 
08/11/2017
Course expires: 
09/20/2019
Cost:
$35.00
Rating: 
0
Faculty Disclosures:

Vivek Bhalla, MD
Assistant Professor
Stanford University
Stanford, CA
Disclosure: The speaker has stock options in Viscira; has received an honoraria from CareDx in the subject of organ transplantation.

Jamie Dwyer, MD
Professor of Medicine
Vanderbilt University Medical Center      
Nashville, TN
Disclosure: The speaker has a relationship as an Associate Editor (journal), but no financial interests, with CardioRenal Medicine on the subject of Cardiorenal Syndrome.

Katherine Tuttle, MD
Executive Director for Research
Providence Health Care
Spokane, WA
Disclosure: The speaker received consulting fees from Boehringer Ingelheim and consulting fees and honoraria from Eli Lilly and Company, all in the subject of Diabetic Kidney Disease.

Planning Committee Disclosures:

Dena Rifkin, MD, MS, FNKF
Physician
VA San Diego
La Jolla, CA
Disclosure: Has no financial relationships with commercial interest(s).

Thomas Nolin, PharmD, PhD
Associate Professor
University of Pittsburgh School of Pharmacy
Pittsburgh, PA
Disclosure: The speaker received consulting fees and travel from AM Pharma and Thrasos Innovation, Inc in the subject of AKI for their role as a consultant and IDMC member, respectively.

Tara Chang, MD, MS
Assistant Professor of Medicine
Stanford University
Palo Alto, CA
Disclosure: Consultant: Janssen; on the subject of Diabetic Nephropathy.

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).
 

Available Credit

  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 CDR CPEUs

Accreditation Period

Course opens: 
08/11/2017
Course expires: 
09/20/2019

Price

Cost:
$35.00
Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals